COYA THERAPEUTICS INC (COYA) Stock News
NASDAQ:COYA - Nasdaq - US22407B1089 - Common Stock - Currency: USD
COYA Latest News, Press Relases and Analysis
Updated Lineup Announced for iAccess Alpha's Virtual Summer Investment Conference, June 24–25, 2025
iAccess Alpha's Virtual Best Ideas Summer Investment Conference June 24-25, 2025
Coya Therapeutics to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24 – 25, 2025
Are Medical Stocks Lagging Auna S.A. (AUNA) This Year?
Here is how Auna S.A. (AUNA) and Coya Therapeutics, Inc. (COYA) have performed compared to their sector so far this year.
Mentions: AUNA
Coya Therapeutics to Participate at the H.C. Wainwright 3rd Annual BioConnect Investor Conference
Coya Therapeutics Reports First Quarter Financial Results and Provides a Corporate Update
Coya Therapeutics to Participate in Two Upcoming Conferences in May 2025
Why Meta Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
Is Coya Therapeutics, Inc. (COYA) Outperforming Other Medical Stocks This Year?
Here is how Coya Therapeutics, Inc. (COYA) and Doximity (DOCS) have performed compared to their sector so far this year.
Mentions: DOCS
Wall Street Analysts See a 144.73% Upside in Coya Therapeutics, Inc. (COYA): Can the Stock Really Move This High?
The consensus price target hints at a 144.7% upside potential for Coya Therapeutics, Inc. (COYA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Atea Pharmaceuticals Appoints Howard H. Berman to Board of Directors and Announces Share Repurchase Program
Enters into Agreement with Bradley L. Radoff and Michael Torok
Mentions: AVIR
Why Kingsoft Cloud Holdings Limited (KC) Surged On Friday?
We recently published a list of Gold, Biopharma Firms Dominate Friday’s 10 Top Performing Stocks. In this article, we are going to take a look at where Kingsoft Cloud Holdings Limited (NASDAQ:KC) stands against other Friday’s top performing stocks. The stock market finished the trading week on a positive note, wiping out earlier losses on Friday, […]
Is Galapagos (GLPG) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?
We recently published a list of Top 9 Healthcare Stocks to Buy According to Billionaire David Einhorn. In this article, we are going to take a look at where Galapagos NV (NASDAQ:GLPG) stands against other top healthcare stocks to buy according to Billionaire David Einhorn. Wall Street has come down crashing on President Donald Trump’s […]
Is Coya Therapeutics (COYA) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?
We recently published a list of Top 9 Healthcare Stocks to Buy According to Billionaire David Einhorn. In this article, we are going to take a look at where Coya Therapeutics, Inc. (NASDAQ:COYA) stands against other top healthcare stocks to buy according to Billionaire David Einhorn. Wall Street has come down crashing on President Donald […]
Is Gain Therapeutics (GANX) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?
We recently published a list of Top 9 Healthcare Stocks to Buy According to Billionaire David Einhorn. In this article, we are going to take a look at where Gain Therapeutics, Inc. (NASDAQ:GANX) stands against other top healthcare stocks to buy according to Billionaire David Einhorn. Wall Street has come down crashing on President Donald […]
Nordic American Tankers Limited (NAT): One of the High-Dividend Stocks to Invest In Under $10
We recently published a list of the 13 High-Dividend Stocks to Invest In Under $10. In this article, we are going to take a look at where Nordic American Tankers Limited (NYSE:NAT) stands against other high-dividend stocks under $10. Investors often favor dividend stocks for their long-term potential, with their appeal stemming from the consistent […]
Coya Therapeutics Selected for Platform Presentation at the ADPD 2025 Conference in Vienna on April 5, 2025
What Makes Coya Therapeutics, Inc. (COYA) a New Buy Stock
Coya Therapeutics, Inc. (COYA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Wall Street Analysts Think Coya Therapeutics, Inc. (COYA) Could Surge 149.62%: Read This Before Placing a Bet
The consensus price target hints at a 149.6% upside potential for Coya Therapeutics, Inc. (COYA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Coya Therapeutics Reports Progress from an Academic Supported First-in-Class Treg-derived Exosome Program
Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2024 Financial Results
Coya Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Coya Therapeutics to Participate in a Fireside Chat at the 7th Annual Evercore HealthCONx Conference
Coya Therapeutics CEO Dr. Arun Swaminathan Issues Letter to Stockholders
Coya Therapeutics Provides a Corporate Update and Reports Unaudited Third Quarter 2024 Financial Results